These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 879736)

  • 21. [In vitro activity of cefotaxime on anaerobes (author's transl)].
    Soussy CJ; Thibault M; Duval J
    Nouv Presse Med; 1981 Feb; 10(8):556-8. PubMed ID: 6259592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial effect of beta-lactam antibiotic combinations against Bacteroides fragilis in vitro.
    Bansal MB; Thadepalli H
    Antimicrob Agents Chemother; 1983 Jan; 23(1):166-8. PubMed ID: 6830206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro and in-vivo activities of a novel cephamycin MT-141 against the Bacteroides fragilis group in comparison with six cephem antibiotics.
    Kasai T; Hara T; Tamura A; Kazuno Y; Inouye S; Goto S; Kuwahara S
    J Antimicrob Chemother; 1985 Jun; 15(6):701-14. PubMed ID: 3928575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotics of choice against Bacteroides fragilis.
    Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
    Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
    Antimicrob Agents Chemother; 1984 Jan; 25(1):131-3. PubMed ID: 6322676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of cefaclor against aerobic and anaerobic bacteria.
    Bach VT; Khurana MM; Thadepalli H
    Antimicrob Agents Chemother; 1978 Feb; 13(2):210-3. PubMed ID: 646343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disc diffusion method to screen for high-level resistance to clindamycin and erythromycin in the Bacteroides fragilis group.
    Callihan DR; Nolte FS
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):131-7. PubMed ID: 3979019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis.
    Privitera G; Dublanchet A; Sebald M
    J Infect Dis; 1979 Jan; 139(1):97-101. PubMed ID: 108340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
    Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
    Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to tetracycline, erythromycin, and clindamycin in the Bacteroides fragilis group: inducible versus constitutive tetracycline resistance.
    Privitera G; Fayolle F; Sebald M
    Antimicrob Agents Chemother; 1981 Sep; 20(3):314-20. PubMed ID: 7305321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis.
    Tally FP; Snydman DR; Gorbach SL; Malamy MH
    J Infect Dis; 1979 Jan; 139(1):83-8. PubMed ID: 438530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of cephazolin and other cephalosporins against Bacteroides fragilis.
    Leigh DA; Simmons K
    Scott Med J; 1976 Sep; 20(5):228-31. PubMed ID: 1265472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of cephalosporins by Bacteroides.
    Tally FP; O'Keefe JP; Sullivan NM; Gorbach SL
    Antimicrob Agents Chemother; 1979 Nov; 16(5):565-71. PubMed ID: 525995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance.
    Jenkins SG; Birk RJ; Zabransky RJ
    Antimicrob Agents Chemother; 1982 Oct; 22(4):628-34. PubMed ID: 7181473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro.
    Ingham HR; Selkon JB; Codd AA; Hale JH
    J Clin Pathol; 1970 Apr; 23(3):254-8. PubMed ID: 5310276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
    Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
    J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
    Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1976 Oct; 10(4):736-52. PubMed ID: 984809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
    Brown JE; Del Bene VE; Collins CD
    Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.